A normal sperm count is 16 million sperm per millilitre or more, according to the WHO 2021 guidelines. Low sperm count (oligospermia) affects roughly 1 in 3 infertile couples in India. Most causes, including lifestyle factors, hormonal imbalance, and varicocele, are treatable through medication, IUI, IVF, or ICSI under specialist care.
In 2021, the World Health Organization published the 6th edition of its Laboratory Manual for the Examination and Processing of Human Semen, replacing the 2010 5th edition benchmarks that most Indian labs had followed for over a decade. The 2021 update is based on data from more than 3,500 fertile men across 12 countries and is now the global standard for interpreting semen analysis. A "normal" sample is not a single number but a set of six parameters measured together. Falling below one threshold does not mean infertility; it means a specialist should investigate further.
The table below summarises the current WHO 2021 lower reference limits. If your report still references older thresholds (15 million/mL concentration, 40% motility, 1.5 mL volume), it is using the superseded 2010 values. Ask your lab to confirm they are reporting against WHO 2021.
Male-factor infertility is no longer a side issue in Indian fertility practice; it is the primary or contributing cause in roughly 50% of all cases. This matches the global pattern: when couples present with difficulty conceiving, the probability that a male factor is involved is the same as the probability of a female factor. Despite this, the workup in many Indian clinics still defaults to investigating the female partner first, often delaying a simple semen analysis that could identify the issue within days.
Indian sperm count trends are particularly concerning. Research indicates average sperm concentrations among Indian men have dropped significantly over the past three decades, with some urban datasets showing declines from around 60 million/mL in the 1980s to about 20 million/mL in recent years. Studies cited by Indian fertility specialists report the rate of sperm count decline has accelerated to roughly 2.6% per year since 2000, a pattern mirrored across Asia, South America, and Africa in the most recent global meta-analyses.
Several factors make the Indian context distinct. Urban men now marry later than previous generations, often in their early to mid-30s, so fertility evaluation often begins at an age where sperm parameters have naturally started to decline. High population density areas, including Delhi NCR, where Gurgaon sits, have measurable air pollution exposure that peer-reviewed studies link to DNA fragmentation in sperm. Sedentary desk work, long commute hours, rising BMI, tobacco and alcohol use, and heat exposure from prolonged laptop use all compound the problem. A modern fertility consultation should begin with the evaluation of both partners simultaneously. This is the single most important change couples can ask for at their first visit.
Male infertility is rarely caused by a single factor. In most cases, it is a combination of lifestyle, medical, and structural factors acting together. Understanding which category applies to you matters because treatment differs dramatically between them. Causes broadly fall into four groups:
This is the most common and often the most reversible category in Indian urban practice. The testes sit outside the body because sperm production (spermatogenesis) functions optimally at 2–3°C below core body temperature. Anything that raises scrotal temperature or disrupts hormonal signalling directly damages sperm production and quality.
Smoking has dose-dependent effects: heavier smokers show lower sperm concentration, poorer motility, and higher DNA fragmentation than non-smokers. Heavy alcohol consumption disrupts testosterone production and impairs sperm maturation. Obesity, particularly central adiposity, converts testosterone to oestrogen in fat tissue, raising eostrogen levels that suppress FSH and LH signalling to the testes. Even moderate weight gain above a healthy BMI measurably lowers sperm count.
Occupational and environmental factors matter more in urban India than global averages suggest. Long hours in air-conditioned vehicles, prolonged laptop use directly on the lap, frequent hot showers, and sauna use all raise scrotal temperature. Workplace chemical exposure (pesticides, solvents, heavy metals such as lead and cadmium), proximity to industrial areas, and chronic high air pollution are all independently associated with reduced semen parameters in Indian studies.
Sperm production depends on a precise hormonal cascade: the hypothalamus signals the pituitary, which releases FSH and LH, which in turn drive the testes to produce testosterone and sperm. Disruption anywhere in this axis reduces fertility.
Primary testicular failure, where the testes themselves cannot produce sperm, shows up as low testosterone with high FSH. Secondary hypogonadism, where the signal from the brain is disrupted, shows up as low testosterone with low or normal FSH. Elevated prolactin, often from pituitary microadenomas, suppresses the entire axis and frequently presents with low libido alongside fertility concerns. Thyroid dysfunction, both under- and overactive, disrupts sperm parameters and should always be checked in the male workup.
Systemic conditions matter too. Type 2 diabetes is strongly associated with reduced sperm motility and increased DNA fragmentation, particularly when glycaemic control is poor. Past genitourinary infections, including mumps orchitis in childhood, untreated STIs, and chronic prostatitis, can scar the reproductive tract or directly damage sperm-producing tissue. Certain medications, including anabolic steroids (unfortunately common in gym settings), some antidepressants, alpha blockers, and a handful of antibiotics, affect sperm production or ejaculation. Chemotherapy and radiation therapy are well-established causes of sperm damage; in some cases, the effect is reversible, in others permanent, which is why sperm banking before cancer treatment is standard clinical practice.
Varicocele, enlarged veins within the scrotum, is found in roughly 40% of men evaluated for infertility and is the single most common correctable structural cause. The mechanism is straightforward: dilated veins disrupt normal blood flow, raising scrotal temperature and causing oxidative stress in the testis. Not all varicoceles need surgery; treatment is recommended when the varicocele is clinically palpable, semen parameters are abnormal, and the couple is pursuing fertility.
Obstructive causes prevent sperm from reaching the ejaculate even when production is normal. These include congenital absence of the vas deferens (seen in men with cystic fibrosis gene mutations), post-infective blockages in the epididymis, and iatrogenic obstructions from previous hernia repair or scrotal surgery. Retrograde ejaculation, where semen travels backwards into the bladder rather than forwards, is often diabetes-related or post-surgical. Undescended testes in childhood, even when surgically corrected, are associated with a higher risk of subfertility later in life. Previous testicular torsion, trauma, or surgery can all affect long-term function.
A smaller but important group of cases involve chromosomal abnormalities or specific genetic conditions. Klinefelter syndrome (47, XXY) is the most common chromosomal cause of azoospermia in men. Y-chromosome microdeletions, small missing sections of DNA on the Y chromosome, cause impaired spermatogenesis in a subset of men with severe oligospermia or azoospermia, and are heritable if sperm retrieval leads to conception. Genetic testing is recommended in men with very low sperm counts or azoospermia before proceeding to ICSI, because identifying specific conditions changes the treatment plan and counselling.
In a meaningful percentage of cases, no identifiable cause is found despite thorough evaluation; this is termed idiopathic male infertility. Even here, treatment outcomes are very good: modern ART techniques, particularly ICSI, can achieve fertilisation with very few viable sperm, meaning biological fatherhood is possible for the vast majority of men, regardless of the underlying cause.
.jpg)
A semen analysis is the single most important diagnostic test for male infertility. It is non-invasive, takes 2–3 days to report, and gives a detailed picture of sperm production and function. Despite its simplicity, it is also one of the most misinterpreted tests in fertility practice because parameters fluctuate naturally.
A proper analysis requires 2–5 days of sexual abstinence before the sample (less than 2 days underestimates count; more than 7 days underestimates motility). The sample should be collected on-site at the lab, ideally, kept at body temperature, and processed within an hour. Any abnormal result should be confirmed on a second sample 2–3 weeks later before drawing conclusions. Single low readings are common in healthy, fertile men after illness, stress, or travel.
Your report will classify findings against WHO 2021 thresholds using specific diagnostic terms:
• Normozoospermia: Normal sperm count, motility, and morphology.
• Oligospermia: Sperm concentration below 16 million/mL is the most common abnormal finding.
• Asthenospermia: Reduced sperm motility below 42% total or 30% progressive.
• Teratospermia: Abnormal sperm shape; normal forms below 4% (strict Kruger criteria).
• Oligoasthenoteratospermia (OAT): Combined low count, motility, and morphology are commonly seen together.
• Azoospermia: No sperm detected in the ejaculate requires further workup to distinguish between obstructive (blockage) and non-obstructive (production failure) causes.
• Cryptozoospermia / retrograde ejaculation: Sperm present in the urine after ejaculation, indicating retrograde ejaculation.
A single abnormal report is not a diagnosis. Beyond repeat testing, your specialist may add hormonal blood tests (FSH, LH, testosterone, prolactin, TSH), scrotal ultrasound to check for varicocele or structural issues, and sperm DNA fragmentation testing. DNA fragmentation is particularly useful when standard parameters look normal, but conception is not happening, or when there have been recurrent miscarriages or failed IVF cycles. For men with azoospermia, genetic testing (karyotype, Y-chromosome microdeletion, CFTR gene for cystic fibrosis carrier status) is standard before any surgical sperm retrieval.
Treatment depends entirely on the underlying cause, baseline semen parameters, the female partner's fertility status, and how long you have been trying. A good fertility specialist will recommend the least invasive option likely to succeed in your specific case, rather than jumping straight to IVF. Treatment falls into two broad categories: medical/surgical interventions aimed at improving sperm output naturally, and assisted reproductive techniques that use available sperm more efficiently.
• Lifestyle correction: Stopping smoking, reducing alcohol intake, weight optimisation, correcting heat exposure, and managing stress can meaningfully improve sperm parameters. The effect typically shows on repeat semen analysis at 3 months, the duration of one full spermatogenesis cycle. For men with mildly abnormal parameters, this is often the only intervention needed.
• Medical therapy for hormonal issues: Hormonal imbalances are treated under andrology supervision based on the specific pattern seen on blood tests. Elevated prolactin, thyroid dysfunction, or selected cases of hypogonadotropic hypogonadism respond well to targeted medical therapy.
• Varicocele surgery: Surgical repair of varicocele (varicocelectomy) can improve sperm concentration, motility, and DNA integrity in appropriately selected cases, typically when the varicocele is clinically palpable, semen parameters are abnormal, and the couple has time to wait for improvement. Repair is not recommended for small, ultrasound-only varicoceles without symptoms or abnormal semen.
• Treating underlying medical conditions: Chronic prostatitis, urinary tract infections, and sexual dysfunction (erectile or ejaculatory difficulty) are addressed before or alongside fertility treatment. Ignoring these undermines any ART cycle that follows.
• Reconstructive surgery: For obstructive azoospermia (production is normal, but sperm cannot exit), microsurgical reconstruction of the vas deferens or epididymis is sometimes possible, particularly after vasectomy reversal.
• IUI (Intrauterine Insemination): Sperm is washed, concentrated, and placed directly into the uterus at the time of ovulation. Best suited for mild to moderate low sperm count, where sperm function is otherwise reasonable, and where the female partner's tubes and ovulation are normal. Typically recommended for 3–4 cycles before moving up.
• IVF (In-vitro Fertilization): Eggs are retrieved from the female partner after stimulation, fertilised in the laboratory with prepared sperm, and the resulting embryo is transferred to the uterus. Best suited for moderate male-factor infertility, especially when combined with any female-factor issues such as tubal disease or endometriosis. Fertilisation rates depend on having enough motile sperm in the ejaculate.
• ICSI (Intracytoplasmic Sperm Injection): A specialised IVF technique where a single healthy sperm is injected directly into each mature egg using a microscopic needle, bypassing the natural barriers to fertilisation. ICSI is the gold standard for severe low sperm count, poor motility, high DNA fragmentation, or previous IVF fertilisation failure. It requires only a handful of viable sperm to achieve fertilisation.
• Surgical sperm retrieval: For men with azoospermia, sperm can often be retrieved directly from the testicular tissue using TESA (needle aspiration), TESE (surgical biopsy), or Micro-TESE (microsurgical retrieval). Retrieved sperm is used with ICSI, usually in the same cycle. Micro-TESE has the highest success rate for non-obstructive azoospermia and is performed under an operating microscope to identify small pockets of tissue still producing sperm.
• Advanced sperm testing and selection: When recurrent IVF failure or unexplained poor embryo development suggests a sperm quality issue beyond what standard analysis reveals, DNA fragmentation testing, advanced sperm selection techniques (IMSI, PICSI, microfluidic selection), and structured male fertility optimisation may improve outcomes.
• Donor sperm: When no sperm can be retrieved, even with Micro-TESE, or when genetic conditions would be transmitted, donor sperm is a medically and legally regulated option in India. This is a significant decision and is always preceded by counselling for both partners.
_11zon.jpg)
Conventional advice has been to wait 12 months of unprotected intercourse before seeking evaluation. This rule is outdated for many Indian couples, particularly those marrying later, where the female partner is over 30, or where there is any known risk factor on either side. Use this table to decide when to book:
Success rates depend on the severity of the male factor,the female partner's age and fertility status, and the treatment selected.These are typical outcomes reported by Indian fertility clinics for a female partner under 35. Outcomes decline with maternal age regardless of the male-factor picture.
